Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management

被引：41
|
作者：
Zajecka, John [1 ,2 ]
Kornstein, Susan G. [3 ,4 ]
Blier, Pierre [5 ,6 ]
机构：
[1] Rush Univ, Depress Treatment Res Ctr, Med Ctr, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[3] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA
[4] Virginia Commonwealth Univ, Inst Womens Hlth, Richmond, VA USA
[5] Univ Ottawa, Dept Psychiat & Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada
[6] Univ Ottawa, Mood Disorders Res Unit, Mental Hlth Res Inst, Royal Ottawa Mental Hlth Ctr Ottawa, Ottawa, ON K1N 6N5, Canada
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2013年 / 74卷 / 04期
关键词：
STAR-ASTERISK-D; PROMOTER POLYMORPHISM; PARTIAL REMISSION; ASSOCIATION; CITALOPRAM; INVENTORY; VALIDITY; EPISODES; RECEPTOR; OUTCOMES;
D O I：
10.4088/JCP.12059ah1
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
[No abstract available]
引用
收藏
页码：407 / 414
页数：8
相关论文
共 50 条
  • [1] Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management (vol 74, pg 407, 2013)
    Zajecka, John
    Kornstein, S. G.
    Blier, P.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (05) : 519 - 519
  • [2] Residual symptoms and recurrence in major depressive disorder
    Spadone, C.
    Corruble, E.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2010, 36 : S108 - S111
  • [3] The challenge of comorbidity and residual symptoms in patients with major depressive disorder
    Lepine, J. P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S93 - S93
  • [4] Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management
    Jaracz, Jan
    Gattner, Karolina
    Jaracz, Krystyna
    Gorna, Krystyna
    [J]. CNS DRUGS, 2016, 30 (04) : 293 - 304
  • [5] Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management
    Jan Jaracz
    Karolina Gattner
    Krystyna Jaracz
    Krystyna Górna
    [J]. CNS Drugs, 2016, 30 : 293 - 304
  • [6] Prevalence and association of somatic symptoms in patients with Major Depressive Disorder
    Vaccarino, Anthony L.
    Sills, Terrence L.
    Evans, Kenneth R.
    Kalali, Amir H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2008, 110 (03) : 270 - 276
  • [7] Prevalence and patterns of major depressive disorder and subthreshold depressive symptoms in south China
    Liao, Dan -Dan
    Dong, Min
    Ding, Kai-Rong
    Hou, Cai-Lan
    Tan, Wen-Yan
    Ke, Yun-Fei
    Jia, Fu-Jun
    Wang, Shi-Bin
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 329 : 131 - 140
  • [8] Number of illness episodes as predictor of residual symptoms in major depressive disorder
    Serafini, Gianluca
    Nebbia, Jacopo
    Cipriani, Nicolo
    Conigliaro, Claudia
    Erbuto, Denise
    Pompili, Maurizio
    Amore, Mario
    [J]. PSYCHIATRY RESEARCH, 2018, 262 : 469 - 476
  • [9] The Search for Consistency in Residual Symptoms in Major Depressive Disorder: A Narrative Review
    Pastuszak, Michal
    Cubala, Wieslaw Jerzy
    Kwasny, Aleksander
    Mechlinska, Agnieszka
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (08):
  • [10] Vortioxetine in the treatment of major depressive disorder, addressing the core and residual symptoms
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Gotor Sanchez-Luengo, F.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S35 - S36
12345